医薬品開発におけるバイオマーカーのジャーナル オープンアクセス

抽象的な

How Biomarker Indicates Change in Expression or State of A Protein

Zuhal Sezgin

Parkinson's disease (PD) is that the most frequent neurodegenerative movement disorder. In near future its importance can increase, particularly because of changes in age structure. There square measure still substantial issues in terms of early diagnosing of the malady. In clinical observe, the diagnosing of metallic element continues to be supported the analysis of clinical presentation and is supported by varied auxiliary tests with heterogeneous prognosticative price

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません